Quince Therapeutics, Inc. (IRLA) Balance Sheet
As of 2026-06-30 (10-Q), Quince Therapeutics, Inc. (IRLA) reported total assets of $124.0M, total liabilities of $15.5M and shareholders' equity of -$35.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $116.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
IRLAQuince Therapeutics, Inc.Follow IRLA — free
—
Price chart with a free account
- Market cap
- 33.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 51.2 | 66.8 | 69.7 | 44.6 | 20.8 | 6.2 | 5.8 | 116.0 | |
| Short-term investments | 48.7 | 67.0 | 37.1 | 45.6 | 54.3 | 34.6 | 11.9 | 0.0 | |
| Receivables | — | — | — | 0.0 | — | — | — | — | |
| Current assets | 106.1 | 137.9 | 111.7 | 93.7 | 77.4 | 44.0 | 22.9 | 123.4 | |
| Total assets | 124.4 | 189.5 | 133.2 | 103.9 | 167.9 | 114.5 | 93.5 | 124.0 | |
| Current liabilities | 8.9 | 17.0 | 14.2 | 3.1 | 9.6 | 7.3 | 43.2 | 8.5 | |
| Long-term debt | — | — | — | 0.0 | 13.4 | 14.3 | 0.0 | — | |
| Short-term debt | — | — | — | — | — | 0.0 | 18.0 | 0.0 | |
| Total liabilities | 8.9 | 17.2 | 14.6 | 3.3 | 82.8 | 84.3 | 129.2 | 15.5 | |
| Shareholders' equity | 115.5 | 172.3 | 118.6 | 100.6 | 85.1 | 30.1 | -35.7 | -35.3 |
USD millions · SEC XBRL
Quince Therapeutics, Inc. — questions
- How much cash does Quince Therapeutics, Inc. have?
- $116.0M in cash and cash equivalents as of 2026-06-30.
- How much debt does Quince Therapeutics, Inc. have?
- $0 due within a year as of 2026-06-30.
- What are Quince Therapeutics, Inc.'s total assets?
- $124.0M as of 2026-06-30.
- What is Quince Therapeutics, Inc.'s shareholders' equity?
- -$35.3M as of 2026-06-30.
Every figure on this page comes from Quince Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.